Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol IR in Acute Pain from Hip Replacement
NCT00364533Phase 3Terminated
- Sponsor
- Johnson & Johnson
- Start
- Oct 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of tapentadol in acute pain, sponsored by Johnson & Johnson. Started Oct 2006; status: terminated.
02
Drugs
tapentadol
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT00364533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00364533.